Haemonetics Corp (HAE)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$60.00
Buy
$73.37
$0.93 (+1.34%)
Prices updated at 16 May 2025, 23:42 EDT
| Prices minimum 15 mins delay
Prices in USD
Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
---|---|---|
1,169m | 1,309m | |
615m | 692m | |
156m | 173m | |
13.32 | 13.24 | |
115m | 118m | |
249m | 262m | |
Sales, General and administrative | 377m | 432m |
Interest expenses | 15m | 13m |
Provision for income taxes | 26m | 34m |
Operating expenses | 459m | 518m |
Income before taxes | 141m | 152m |
Net income available to common shareholders | 115m | 118m |
2.5 | 2.56 | |
Net interest income | -15m | -13m |
Advertising and promotion | - | - |
Net investment income, net | - | - |
Realised capital gains (losses), net | - | - |
Total benefits, claims and expenses | - | - |
Earnings per share (diluted) | 2.46 | 2.54 |
Free cash flow per share | 3.8826 | 0.3958 |
Book value/share | 17.5969 | 17.4948 |
Debt equity ratio | 0.921888 | 0.830831 |
Balance sheet
Year | 2023 | 2024 |
---|---|---|
Current assets | 770m | 769m |
Current liabilities | 252m | 300m |
Total capital | 1,572m | 1,758m |
Total debt | 766m | 808m |
Total equity | 818m | 960m |
Total non current liabilities | - | - |
Loans | 754m | 798m |
Total assets | 1,935m | 2,196m |
Total liabilities | - | - |
Cash and cash equivalents | 284m | 179m |
Common stock | 50m | 51m |
Cash flow
Year | 2023 | 2024 |
---|---|---|
Cash at beginning of period | 259m | 284m |
Cash dividends paid | - | - |
163m | 115m | |
Investments (gains) losses | -144m | -322m |
284m | 179m | |
Net income | - | - |
273m | 182m | |
-110m | -66m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.